Please login to the form below

Not currently logged in
Email:
Password:

Ex-Roche CMO Sandra Horning joins Gilead’s board of directors

Horning retired from Roche last August

Sandra Horning

Sandra Horning (pictured above) has joined the board of directors at Gilead, shortly after retiring from her role as chief medical officer and global head of product development at Roche. 

During her ten-year career at Roche, Horning helped to bring 15 new medicines to patients in a range of diseases, including cancer, multiple sclerosis, influenza and blindness.

Prior to Roche, she spent 25 years as a practicing oncologist, investigator and tenured professor at Stanford University of Medicine, where she remains an Emerita Professor.

In addition, from 2015 to 2018 Horning served on the Foundation Medicine Board of Directors, and she currently serves as an advisor to EQRx, of which she is a co-founder.

Horning has also recently joined the board of directors at Moderna, a clinical-stage biotechnology company based in Cambridge, Massachusetts.

She was nominated as a class two director and will also serve as a member of the product development committee of the board.

Horning received her MD from University of Iowa School of Medicine, and completed her post-graduate fellowship in Oncology and Cancer Biology at Stanford University.O'DAY

“We are very pleased to welcome Sandra Horning to our Board of Directors,” said Daniel O’Day (pictured right), chairman and chief executive officer of Gilead Sciences.

“Sandra has significant industry expertise and vast experience in drug development across multiple therapeutic areas. In addition, she brings the perspective of a leading physician who has spent more than two decades caring for patients with cancer.

“Sandra’s presence on our board will be a tremendous asset as we enter the next chapter for Gilead with the goal of rapidly advancing new, transformative medicines,” he added.

Article by
Lucy Parsons

4th February 2020

From: Research

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Wilmington Healthcare

A heritage to envy Wilmington Healthcare brings together the data intelligence specialisms of Binley’s, NHiS, Wellards and HSJ to create...

Latest intelligence

Deep 6 AI: the smart software breathing new life into clinical trials
Fishawack Health interviews Wout Brusselaers, the Deep 6 AI CEO using artificial intelligence to solve one of the greatest barriers stagnating healthcare innovation—clinical trial recruitment and retention....
COVID-proof: How Teams are Creating Launch Intensity thru Adversity
Now that the game has changed, how are marketers shifting their launch behaviour? We've identified 5 common observations from effective teams....
5 ways that lockdowns and restrictions could be affecting our allergies
Over this last year, lockdowns and restrictions have led to changes in the day-to-day environments for people across the world. For Allergy Awareness week, we wanted to explore some of...